PCA
PFE icon

Peddock Capital Advisors’s Pfizer PFE Stock Holding History

Peddock Capital Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$977K Hold
34,780
– – 0.22% 82
2025
Q4 		$866K Sell
34,780
-1,010
-3% -$25.5K 0.18% 85
2025
Q3 		$912K Sell
35,790
-421
-1% -$10.4K 0.2% 82
2025
Q2 		$878K Hold
36,211
– – 0.2% 82
2025
Q1 		$918K Hold
36,211
– – 0.23% 81
2024
Q4 		$961K Sell
36,211
-3,430
-9% -$93K 0.23% 82
2024
Q3 		$1.15M Sell
39,641
-54
-0.1% -$1.57K 0.28% 74
2024
Q2 		$1.11M Buy
39,695
+1,807
+5% +$49.7K 0.29% 76
2024
Q1 		$1.05M Hold
37,888
– – 0.28% 82
2023
Q4 		$1.09M Sell
37,888
-10,856
-22% -$328K 0.33% 73
2023
Q3 		$1.62M Sell
48,744
-3,552
-7% -$126K 0.54% 47
2023
Q2 		$1.92M Sell
52,296
-14,875
-22% -$579K 0.63% 41
2023
Q1 		$2.74M Buy
67,171
+4,038
+6% +$174K 0.95% 24
2022
Q4 		$3.23M Buy
63,133
+9,556
+18% +$458K 1.25% 16
2022
Q3 		$2.35M Sell
53,577
-95
-0.2% -$4.62K 0.96% 22
2022
Q2 		$2.81M Sell
53,672
-292
-0.5% -$14.9K 1.1% 19
2022
Q1 		$2.79M Buy
53,964
+1,019
+2% +$52.9K 0.91% 23
2021
Q4 		$3.13M Buy
52,945
+225
+0.4% +$11.1K 1.03% 21
2021
Q3 		$2.27M Buy
52,720
+267
+0.5% +$11.8K 0.81% 31
2021
Q2 		$2.25M Buy
52,453
+305
+0.6% +$11.9K 0.78% 32
2021
Q1 		$1.89M Buy
52,148
+3,539
+7% +$126K 0.72% 38
2020
Q4 		$1.79M Sell
48,609
-284
-0.6% -$10.4K 0.93% 27
2020
Q3 		$1.7M Sell
48,893
-1,950
-4% -$68.4K 1.04% 27
2020
Q2 		$1.58M Buy
50,843
+861
+2% +$29.3K 0.99% 25
2020
Q1 		$1.55M Sell
49,982
-3,006
-6% -$102K 1.16% 20
2019
Q4 		$1.97M Sell
52,988
-4,207
-7% -$150K 1.01% 18
2019
Q3 		$1.95M Sell
57,195
-176
-0.3% -$6.4K 1.08% 15
2019
Q2 		$2.36M Buy
57,371
+1,171
+2% +$46.5K 1.26% 14
2019
Q1 		$2.27M Buy
56,200
+9,550
+20% +$382K 1.23% 12
2018
Q4 		$1.93M Buy
46,650
+4,582
+11% +$190K 1.15% 13
2018
Q3 		$1.76M Hold
42,068
– – 0.85% 19
2018
Q2 		$1.45M Hold
42,068
– – 0.72% 23
2018
Q1 		$1.42M Sell
42,068
-1,460
-3% -$50.2K 0.75% 25
2017
Q4 		$1.5M Hold
43,528
– – 0.75% 24
2017
Q3 		$1.47M Sell
43,528
-78
-0.2% -$2.51K 0.76% 23
2017
Q2 		$1.39M Hold
43,606
– – 0.74% 24
2017
Q1 		$1.42M Sell
43,606
-1,251
-3% -$39.4K 0.82% 19
2016
Q4 		$1.38M Buy
44,857
+211
+0.5% +$6.44K 0.81% 18
2016
Q3 		$1.44M Hold
44,646
– – 0.88% 16
2016
Q2 		$1.49M Buy
44,646
+147
+0.3% +$4.69K 0.95% 14
2016
Q1 		$1.25M Hold
44,499
– – 0.95% 19
2015
Q4 		$1.36M Buy
44,499
+893
+2% +$28.1K 1.04% 17
2015
Q3 		$1.3M Sell
43,606
-935
-2% -$30K 1.18% 17
2015
Q2 		$1.42M Hold
44,541
– – 1.15% 15
2015
Q1 		$1.47M Hold
44,541
– – 1.21% 14
2014
Q4 		$1.32M Hold
44,541
– – 1.07% 14
2014
Q3 		$1.25M Hold
44,541
– – 1.02% 19
2014
Q2 		$1.25M Hold
44,541
– – 0.94% 20
2014
Q1 		$1.36M Hold
44,541
– – 1.06% 14
2013
Q4 		$1.29M Buy
+44,541
New +$1.3M 1% 13

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Peddock Capital Advisors's PFE Position: Q1 2026 in Review

Peddock Capital Advisors held its Pfizer (PFE) position steady in Q1 2026 at 34,780 shares worth $977K. The position accounts for 0.22% of the portfolio, ranked #82.

Peddock Capital Advisors first reported a position in PFE in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.23M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Peddock Capital Advisors held 34,780 shares of Pfizer worth $977K as of Q1 2026.
  • Peddock Capital Advisors left its Pfizer share count unchanged in Q1 2026.
  • Pfizer made up 0.22% of Peddock Capital Advisors's portfolio in Q1 2026, its #82 holding.
  • Peddock Capital Advisors first reported a position in Pfizer in Q4 2013 and has held it in 50 quarters since.
  • Peddock Capital Advisors's Pfizer position peaked at $3.23M in Q4 2022.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Peddock Capital Advisors's 13F filing for Q1 2026, filed 15 Apr 2026.